HLA-DP based resistance to Hodgkin's disease

Multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program in patients with advanced gynecological cancers: A prospective study.

Gynecologic oncology·2025

Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients.

Gynecologic oncology·2019

Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC).

Gynecologic oncology·2017

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Haemodynamic response to exercise in patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction.

Heart (British Cardiac Society)·2026

Optimizing treatment of proximal thoracic aortic graft infections.

JTCVS open·2026

Staged cardiac and pulmonary resection for primary cardiac sarcoma.

JTCVS open·2026

Bicuspid versus tricuspid aortic valve morphology in elective ascending aortic aneurysm surgery: A propensity score-matched analysis.

JTCVS open·2026

Association between preoperative neutrophil-to-lymphocyte ratio and outcomes after deep hypothermic circulatory arrest: A cohort study of 1300 patients.

JTCVS open·2026

Impact of valve position and prosthesis type on outcomes of valve replacement in end-stage renal disease patients with infective endocarditis.

JTCVS open·2026

Related Experiment Videos

HLA-DP based resistance to Hodgkin's disease

Related Concept Videos

Multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program in patients with advanced gynecological cancers: A prospective study.

Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.

Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I.

Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients.

Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study.

Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC).

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Haemodynamic response to exercise in patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction.

Optimizing treatment of proximal thoracic aortic graft infections.

Staged cardiac and pulmonary resection for primary cardiac sarcoma.

Bicuspid versus tricuspid aortic valve morphology in elective ascending aortic aneurysm surgery: A propensity score-matched analysis.

Association between preoperative neutrophil-to-lymphocyte ratio and outcomes after deep hypothermic circulatory arrest: A cohort study of 1300 patients.

Impact of valve position and prosthesis type on outcomes of valve replacement in end-stage renal disease patients with infective endocarditis.

Related Experiment Videos

HLA-DP based resistance to Hodgkin's disease

Related Concept Videos

Related Articles